Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Diabetes Your Type: Testimonial by Dr. Bassam​

Diabetes Your Type: Testimonial by Dr. Bassam​

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE

Atopic Dermatitis story

Atopic Dermatitis story

Use of Lipid-Lowering Therapies Over 2 Years

Use of Lipid-Lowering Therapies Over 2 Years

T1DM Mini-Series: Relevance of Edition JUNIOR trial results for the HCP and Patient life

T1DM Mini-Series: Relevance of Edition JUNIOR trial results for the HCP and Patient life